Another Patent-Infringement Setback for Myriad Genetics

Myriad Genetics Inc. failed to convince a federal court to block a competitor from selling its own genetic tests while another patent-infringement case is pending.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.